CD19 CAR T-Cell Therapy for R/R Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia

Conditions:   B-Cell Non Hodgkin Lymphoma;   B-Cell Acute Lymphoblastic Leukemia Intervention:   Biological: anti-CD19 CAR T-cells Sponsors:   Vinmec Research Institute of Stem Cell and Gene Technology;   National Institute of Hematology and Blood Transfusion, Vietnam Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials